Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival
暂无分享,去创建一个
G. Böning | C. Auernhammer | C. Spitzweg | F. Gildehaus | W. Fendler | M. Unterrainer | A. Gosewisch | H. Ilhan | V. Wenter | A. Todica | P. Bartenstein | F. Gildehaus | S. Rudisile | Wolfgang P. Fendler | W. Fendler